UroToday - Bladder Cancer

Home

Bladder Cancer

UroToday's Bladder Cancer section is a repository of the clinical publications, clinical trials and investigative science pertaining to the diagnosis and treatment of bladder cancer. Also available are conference coverage for all timely bladder cancer science, audio podcasts and downloadable slides from UroToday's slide library.

Online Urology & Urologic Oncology Journal
Please read about the UroToday International Journal; We welcome submissions year round and are committed to providing fast-tracked, peer reviewed publication.
/td>

Display

results per page

Results 151 - 200 of 632

<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Long-Term Outcome of Home Dipstick Testing for Hematuria - Abstract
Wednesday, 16 January 2008
Department of Urology, Strong Memorial Hospital, University of Rochester School of Medicine, 601 Elmwood Avenue, Box 656, Rochester, NY, 14642, USA
read more

Beyond the Abstract - p53 Gene and Protein Status: The Role of p53 Alterations in Predicting Outcome in Patients with Bladder Cancer
Tuesday, 15 January 2008
BERKELEY, CA (UroToday.com) - The function of the normal product of the TP53 gene, the p53 protein, forms the crucial basis of normal cell biology; conversely, the dysfunction of its mutant protein product underlies altered cellular response in cancer.
read more

Beyond the Abstract - The Value of Combined Use of Survivin, Cytokeratin 20 and Mucin 7 mRNA for Bladder Cancer Detection in Voided Urine
Tuesday, 15 January 2008
BERKELEY, CA (UroToday.com) - This study analyzed the clinical value of combined use of survivin, cytokeratin (CK) 20, and mucin (MUC) 7 mRNA in the detection of bladder cancer patients in China.
read more

Inactivation of the Rb Pathway and Overexpression of Both Isoforms of E2F3 are Obligate Events in Bladder Tumours with 6p22 Amplification - Abstract
Monday, 14 January 2008
Cancer Research UK Clinical Centre, Leeds Institute of Molecular Medicine, St James's University Hospital, Leeds, UK
read more

Gemcitabine in Bladder Cancer - Abstract
Friday, 11 January 2008
Centre Léon Bérard, Department of Medical Oncology, 28 Rue Laennec, 69008, Lyon, France
read more

Analysis of a Computer Based Simulator as an Educational Tool for Cystoscopy: Subjective and Objective Results - Abstract
Friday, 11 January 2008
Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota 55906, USA Resident education in cystoscopy has traditionally relied on clinical instruction.
read more

The Value of Combined Use of Survivin, Cytokeratin 20 and Mucin 7 mRNA for Bladder Cancer Detection in Voided Urine - Abstract
Wednesday, 09 January 2008
Department of Urology, Guangdong Provincial People’s Hospital, Number 106, the 2nd Road of Zhongshan, Guangzhou, Guangdong, 510080, China
read more

Evaluation of Laparoscopic Radical Cystectomy for Loco-Regionally Advanced Bladder Cancer - Abstract
Wednesday, 09 January 2008
Department of Urology, All India Institute of Medical Sciences, New Delhi, 110029, India
read more

p53 Gene and Protein Status: The Role of p53 Alterations in Predicting Outcome in Patients with Bladder Cancer - Abstract
Wednesday, 09 January 2008
Department of Pathology, University of Southern California Keck School of Medicine, Los Angeles, CA 90033, USA
read more

Beyond the Abstract - Bladder-Sparing, Combined-Modality Approach for Muscle-Invasive Bladder Cancer : A Multi-Institutional, Long-Term Experience
Tuesday, 08 January 2008
BERKELEY, CA (UroToday.com) -The standard of care for localized muscle-invasive bladder cancer is radical cystectomy.
read more

Case-Control Study of High Risk Occupations for Bladder Cancer in New Zealand - Abstract
Friday, 04 January 2008
Centre for Public Health Research, Massey University, Wellington, New Zealand
read more

Lymphatic Vessel Density and Function in Experimental Bladder Cancer - Abstract
Friday, 04 January 2008
read more

Florida Bladder Cancer Trends 1981 to 2004: Minimal Progress in Decreasing Advanced Disease
Thursday, 03 January 2008
BERKELEY, CA (UroToday.com) - There has been significant decreases in the incidence of advanced stage breast, prostate, and colon cancer primarily from active cancer screening programs.
read more

Gain of 5p15.33 is Associated with Progression of Bladder Cancer - Abstract
Wednesday, 02 January 2008
Department of Urology, Yamaguchi University School of Medicine, Ube, Japan
read more

Association of Cyclin D1 and E1 Expression with Disease Progression and Biomarkers in Patients with Nonmuscle-Invasive Urothelial Cell Carcinoma of the Bladder - Abstract
Wednesday, 02 January 2008
Department of Urology, University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390-9110, USA
read more

[Are There Any Differences between the Characteristics and the Behavior of Bladder Cancer According to the Age of Presentation? Our Experience] - Abstract
Tuesday, 01 January 2008
Servicio Urología, Hospital Universitario Miguel Servet, Zaragoza
read more

Bladder-Sparing, Combined-Modality Approach for Muscle-Invasive Bladder Cancer : A Multi-Institutional, Long-Term Experience - Abstract
Tuesday, 01 January 2008
Comprehensive Urology Unit, National Tumor Institute, "G. Pascale" Foundation, Naples, Italy
read more

The Best Treatment for High-Grade T1 Bladder Cancer is Cystectomy - Abstract
Tuesday, 01 January 2008
Department of Urology, Keck University of Southern California School of Medicine, Los Angeles, CA 90089, USA
read more

Prognostic Significance of HIF-1alpha Polymorphisms in Transitional Cell Carcinoma of the Bladder - Abstract
Monday, 31 December 2007
Department of Urology, Akita University School of Medicine, Akita, Japan
read more

Bladder Cancer after Radiotherapy for Prostate Cancer: Detailed Analysis of Pathological Features and Outcome after Radical Cystectomy - Abstract
Saturday, 29 December 2007
Department of Urology, University of Miami Miller School of Medicine, Miami, Florida, USA
read more

A Prospective Study Evaluating Surgery and Chemo Radiation in Muscle Invasive Bladder Cancer - Abstract
Friday, 28 December 2007
Department of Radiotherapy, Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi-110 029, India
read more

Multiple Biomarkers Improve Prediction of Bladder Cancer Recurrence and Mortality in Patients Undergoing Cystectomy - Abstract
Friday, 28 December 2007
Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas
read more

Hypermethylation of Cell-Free Serum DNA Indicates Worse Outcome in Patients with Bladder Cancer - Abstract
Wednesday, 26 December 2007
Klinik und Poliklinik für Urologie, Universitätsklinikum Bonn, Rheinische-Friedrich-Wilhelms-Universität Bonn, Germany
read more

The Diagnostic Efficacy of Urinary TGF-Beta1 and VEGF in Bladder Cancer: Comparison with Voided Urine Cytology - Abstract
Wednesday, 26 December 2007
Oncology Diagnostic Unit, Medical Biochemistry Department, Faculty of Medicine, Ain Shams University, Cairo, Egyp
read more

Similarity Classifier in Diagnosis of Bladder Cancer - Abstract
Tuesday, 25 December 2007
Laboratory of Applied Mathematics, Lappeenranta University of Technology, P.O. Box 20, FIN-53851 Lappeenranta, Finland\
read more

Conservative Management of Low Risk Superficial Bladder Tumors - Abstract
Monday, 24 December 2007
Division of Urologic Surgery, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA
read more

Novel Agents for Muscle-Invasive and Advanced Urothelial Cancer - Abstract
Monday, 24 December 2007
US Oncology Research, and Baylor College of Medicine, Houston, TX, USA
read more

Role of Urinary Cathepsin B and L in the Detection of Bladder Urothelial Cell Carcinoma
Friday, 21 December 2007
BERKELEY, CA (UroToday.com) - This article evaluates three different urinary markers for the detection and staging of non-invasive bladder cancer; Cathepsin B and L and NMP-22.
read more

Beyond the Abstract - Cathepsin B is Involved in the Apoptosis Intrinsic Pathway Induced by Bacillus Calmette-Guérin in Transitional Cancer Cell Lines
Friday, 21 December 2007
BERKELEY, CA (UroToday.com) - This is a basic research work, where we analyzed the direct effect of BCG on transitional cancer cells (TCC) murine (MB49) and human (T24) cells lines.
read more

History of Bacillus Calmette-Guerin and Bladder Cancer: An Immunotherapy Success Story - Abstract
Thursday, 20 December 2007
Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
read more

The Will Rogers Phenomenon in Urological Oncology - Abstract
Wednesday, 19 December 2007
Department of Surgery, Section of Urology, University of Chicago, Chicago, Illinois
read more

NMP22 Expert Answers
Tuesday, 18 December 2007
BERKELEY, CA (UroToday.com) - The following are common inquiries based on recent medical meetings with answers by Barry Stein, MD.
read more

Prognostic Impact of Comorbidity in Patients with Bladder Cancer - Abstract
Monday, 17 December 2007
Division of Urology, Washington University School of Medicine, St Louis, MO, USA
read more

Immunocytology in the Assessment of Patients with Painless Gross Haematuria - Abstract
Monday, 17 December 2007
read more

Case-Control Study of High Risk Occupations for Bladder Cancer in New Zealand
Friday, 14 December 2007
BERKELEY, CA (UroToday.com) -This article published in International Journal of Cancer identifies the high-risk occupations for the development of bladder cancer in New Zealand workers.
read more

Prognostic Factors in Stage T1 Bladder Cancer: Tumor Pattern (solid or papillary) and Vascular Invasion more Important than Depth of Invasion - Abstract
Friday, 14 December 2007
Department of Urology, Sahlgrenska University Hospital, Göteborg, Sweden
read more

Urinary Bladder Adenocarcinoma Arising in a Spina Bifida Patient - Abstract
Friday, 14 December 2007
Department of Pathology, The Mount Sinai School Of Medicine, New York, NY 10029, USA
read more

Beyond the Abstract - Midkine Promoter-Based Conditionally Replicative Adenovirus for Targeting MIDKINE-Expressing Human Bladder Cancer Model
Thursday, 13 December 2007
BERKELEY, CA (UroToday.com) - Conditionally replicative adenovirus (CRAD) is now widely used and has two major advantages for cancer gene therapy. The virus kills tumor cells selectively because tumor specific promoter controls the expression of E1a gene.
read more

Activity of Endovesical Gemcitabine in BCG-Refractory Bladder Cancer Patients: A Translational Study - Abstract
Thursday, 13 December 2007
Department of Urology, Morgagni-Pierantoni Hospital, Forlì, Italy
read more

Beyond the Abstract - Non-Steroidal Anti-Inflammatory Drugs in the Treatment of Genitourinary Malignancies: Focus on Clinical Data
Wednesday, 12 December 2007
BERKELEY, CA (UroToday.com) - Non-steroidal anti-inflammatory drugs (NSAIDs) have been available for many years and exert their anti-inflammatory effects primarily through inhibition of the cyclooxygenase (COX) enzymes.
read more

Bladder-sparing, Combined-Modality Approach for Muscle-Invasive Bladder Cancer
Wednesday, 12 December 2007
BERKELEY, CA (UroToday.com) - This article published in the journal Cancer, details the complete response rate, disease-specific, and overall survival of patients with cT2-cT4 transitional cell carcinoma to combined transurethral tumor resection, chemotherapy, and radiation therapy.
read more

Does Photodynamic Transurethral Resection of Bladder Tumour Improve the Outcome of Initial T1 High-Grade Bladder Cancer? A Long-Term Follow-Up of a Randomized Study - Abstract
Wednesday, 12 December 2007
Department of Urology, University of Regensburg, Regensburg, and Institute of Pathology, University Hospital RWTH Aachen, Aachen, Germany
read more

Pathological Variants of Invasive Bladder Cancer According to their Suggested Clinical Significance - Abstract
Tuesday, 11 December 2007
Urology, Reina Sofia University Hospital and Cordoba University Medical School, Cordoba, Spain
read more

SUO 2007 - Impact of Clinical Factors Including a Point-of-Care Assay and Cytology on Risk of Bladder Cancer
Monday, 10 December 2007
by: Yair Lotan, MD, Georg C. Hutterer, MD, Shahrokh F. Shariat, MD, and Pierre I. Karakiewicz, MD
Login to read more...

SUO 2007 - Efficacy of Nuclear Matrix Protien 22 Asay for Detection of Upper Tract Urothelial Carcinoma
Monday, 10 December 2007
by: Ithaar H. Derweesh, MD, John B. Malcolm, MD, Christopher J. DiBlasio, MD, Stephanie Hughes, MD, Reza Mehrazin, MD, Anthony L. Patterson, MD, and Robert W. Wake, MD
Login to read more...

A Single-Nucleotide Polymorphism in the Matrix Metalloproteinase-1 Promoter Enhances Bladder Cancer Susceptibility - Abstract
Monday, 10 December 2007
Department of Urology, Bakirkoy Dr Sadi Konuk Research and Training Hospital, Istanbul, Turkey
read more

Cathepsin B is Involved in the Apoptosis Intrinsic Pathway Induced by Bacillus Calmette-Guérin in Transitional Cancer Cell Lines - Abstract
Friday, 07 December 2007
Research Area from Instituto de Oncología Angel H. Roffo, Universidad de Buenos Aires, Buenos Aires, Argentina
read more

An Alternatively Spliced KAI1 mRNA is Expressed at Low Levels in Human Bladder Cancers and Bladder Cancer Cell Lines and is not Associated with Invasive Behaviour - Abstract
Thursday, 06 December 2007
Oncology Research Centre, Prince of Wales Hospital, Randwick, New South Wales, Faculty of Medicine, University of New South Wales, New South Wales, Australia
read more

Urological Implications of Concurrent Bladder and Lung Cancer - Abstract
Thursday, 06 December 2007
Department of Urology, Meir Medical Center, Kfar Saba, Israel
read more

Five-Year, Disease-Free Survival after Repeat Palliative Multimodality Therapy in a Patient with Recurrent Metastatic Bladder Cancer - Abstract
Wednesday, 05 December 2007
Division of Hematology and Oncology, Department of Internal Medicine, Sana Hospital Lübeck, Kronsforder Allee 72-74, D-23560 Lübeck, Germany
read more

Bladder Cancer In Conferences

New!

Bladder Cancer Highlights

- EAU 2008

Late Breaking Developments: Transitional Cell Carcinoma

- SUO 2007

Non-muscle Invasive Bladder Cancer - AUA Guidelines

- SUO 2007

Non-muscle Invasive Bladder Cancer - SIU Guidelines

- SUO 2007

Minimally Invasive Approaches in the Treatment of Urothelial Carcinoma

- Multimedia Presentation by Douglas S. Scherr, MD, from the NY Section of the AUA 2007 Annual Meeting

The Value of Lymph Node Dissection in Bladder, Testes, Prostate and Renal Cell Cancer Surgery

NY Section of the AUA 2007 Annual Meeting

Late Breaking Developments: Transitional Cell Carcinoma

SUO 2007

Non-muscle Invasive Bladder Cancer - AUA Guidelines

SUO 2007

Impact of Clinical Factors Including a Point-of-Care Assay and Cytology on Risk of Bladder Cancer

SUO 2007

The Oncologic Outcomes in Women Undergoing Radical Cystectomy and Orthotopic Urinary Diversion in Women for Transitional Cell Carcinoma of the Bladder

URS 2007

Bladder Cancer Highlights

AUA 2007

ACOG Scientific News Brief: Bladder Cancer Detection in Women

ACOG - Clinical Brief

Detection Of Bladder Cancer In Women Using A Point-Of-Care Assay

Society of Gynecologic Investigation - 2006 Annual Scientific Meeting,

Focus on Bladder Cancer

Katz MD & Salup MD on Improved Detection and Surveillance of Bladder Cancer
Improved Detection and Surveillance of Bladder Cancer Using a Point-of-Care NMP22 Assay

Soloway MD on Diagnosing Bladder Cancer

Improving the Diagnosis of Bladder Cancer -Combining Cystoscopy with a Physician's Office Tumor Marker Test - CME Training Program

Stein MD on Improved Detection of Bladder Cancer in Diagnosis

Improved Detection of Bladder Cancer in Diagnosis and Surveillance Patients Using a Point-of-Care Proteomic Assay

Lotan MD on Screening for Bladder Cancer

Should We Screen for Bladder Cancer in a High Risk Population: A Cost per Life-Year Saved Analysis?

Katz MD Reports on Increased Risk for Bladder Cancer

Wisconsin Industrial Workers Might Be At Increased Risk For Bladder Cancer

Katz MD on the Utility of NMP22 Bladdercheck

Utility of NMP22 BladderCheck Point-Of-Care Assay In Evaluation Of Hematuria: A Multicenter Study

Grossman, MD & the NMP22 Clinical Investigation Group on the Initial Diagnosis of Bladder Cancer

Initial Diagnosis Of Bladder Cancer Using A Point-Of-Care Assay

Bladder Cancer Viewpoints

BJU Int Mini Reviews

- Upper Urinary Tract Tumour After Radical Cystectomy for Transitional Cell Carcinoma of the Bladder: An Update on the Risk Factors, Surveillance Regimens and Treatments |

View PDF

BJU Int Mini Reviews

- The Modern Management of Upper Tract Urothelial Cancer: Surgical Treatment |

View PDF